Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 21-30 of 59 (Search time: 0.003 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosisThakkar, V.; Stevens, W.; Prior, D.; Moore, O.; Byron, J.; Patterson, K.; Hissaria, P.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Celermajer, D.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.; ARA-RHPA 53rd Annual Scientific Meeting (12 May 2012 - 15 May 2012 : Canberra, ACT)
2012An immunochip based interrogation of scleroderma susceptibility variantsCharlesworth, J.; Stankovich, J.; Lewis, P.; Byron, J.; Stevens, W.; Sahhar, J.; Roddy, J.; Nash, P.; Tymms, K.; Rischmueller, M.; Lester, S.; Brown, M.; Proudman, S.; Zochling, J.; ARA-RHPA 53rd Annual Scientific Meeting (12 May 2012 - 15 May 2012 : Canberra, ACT)
2019The economic burden of systemic sclerosis related pulmonary arterial hypertension in AustraliaMorrisroe, K.; Stevens, W.; Sahhar, J.; Ngian, G.-S.; Ferdowsi, N.; Hansen, D.; Patel, S.; Hill, C.L.; Roddy, J.; Walker, J.; Proudman, S.; Nikpour, M.
2014Cost savings with a biomarker-based screening algorithm for pulmonary arterial hypertension in systemic sclerosisQuinlivan, A.; Thakkar, V.; Stevens, W.; Prior, D.; Rabusa, C.; Youssef, P.; Gabbay, E.; Roddy, J.; Walker, J.; Zochling, J.; Sahhar, J.; Nash, P.; Lester, S.; Hill, C.; Rischmueller, M.; Proudman, S.; Nikpour, M.; Australian Rheumatology Association 55th Annual Scientific Meeting (17 May 2014 - 20 May 2014 : Hobart, Tasmania)
2013Early mortality in systemic sclerosis: rationale for forming a multinational inception cohort of patients with scleroderma (the Insync Study)Nikpour, M.; Proudman, S.; Zochling, J.; Sahhar, J.; Nash, P.; Youssef, P.; Major, G.; Roddy, J.; Thakkar, V.; Walker, J.; Stevens, W.; Australian Rheumatology Association 54th Annual Scientific Meeting (18 May 2013 - 22 May 2013 : Perth, W.A.)
2012Serum ICAM-1 levels are related to the presence of interstitial lung disease in SScThakkar, V.; Patterson, K.; Stevens, W.; Byron, J.; Moore, O.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Youssef, P.; Proudman, S.; Hissaria, P.; Nikpour, M.; 2nd Systemic Sclerosis World Congress (2 Feb 2012 - 4 Feb 2012 : Madrid, Spain)
2020Performance of the 2017 EUSTAR activity index in an scleroderma cohortRoss, L.; Stevens, W.; Wilson, M.; Huq, M.; Strickland, G.; Walker, J.; Sahhar, J.; Ngian, G.S.; Roddy, J.; Youssef, P.; Proudman, S.; Nikpour, M.
2021Cost‐effectiveness of combination therapy for patients with systemic sclerosis–related pulmonary arterial hypertensionTran‐Duy, A.; Morrisroe, K.; Clarke, P.; Stevens, W.; Proudman, S.; Sahhar, J.; Nikpour, M.
2019IFNL3 genotype is associated with pulmonary fibrosis in patients with systemic sclerosisMetwally, M.; Thabet, K.; Bayoumi, A.; Nikpour, M.; Stevens, W.; Sahhar, J.; Zochling, J.; Roddy, J.; Tymms, K.; Strickland, G.; Lester, S.; Rischmueller, M.; Ngian, G.-S.; Walker, J.; Hissaria, P.; Shaker, O.; Liddle, C.; Manolios, N.; Beretta, L.; Proudman, S.; et al.
2019Significance of anti-neutrophil cytoplasmic antibodies in systemic sclerosisMoxey, J.; Huq, M.; Proudman, S.; Sahhar, J.; Ngian, G.S.; Walker, J.; Strickland, G.; Wilson, M.; Ross, L.; Major, G.; Roddy, J.; Stevens, W.; Nikpour, M.